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Summary The reduction in size of the experimental ISIS 130 tumour has been investigated in LOU rats
under the influence of increasing doses of cytostatic agents belonging to different classes. External
temperatures of tumours as well as rectal temperatures have been measured at the same time, twice daily,
during the whole experiment. The greater the decrease in the tumour size after drug administration, the larger
was the decrease in external temperature of tumour. The rectal temperatures remained fairly stable, thus
differences between the tumour and rectal temperatures increased. A possible correlation between the
reduction of tumour size and the decrease of external temperature of tumour has been traced for every
cytostatic agent, and the same linear relationship has been found to link these two parameters. The decrease
in external temperature of tumour may, moreover, predict the decrease in tumour size within a term of 1-2
days. Measurement of the magnitude of the transient tumour hypothermia of ISIS 130, following
chemotherapy, would represent a new method for measuring the efficiency and duration of action of
cytostatic agents.
In evaluating the anti-tumour efficiency of
cytostatic drugs, clinicians measure tumour size at
clinical examination, or use radiological, echo-
graphical or CT-scanning techniques. Tumour size,
however, decreases only with some delay after
drug administration, whereas drugs begin to act as
soon as they are administered. Although tumour
markers are certainly useful in specific cases, there
is a need for early and accurate methods for
measuring drug efficiency in cancer patients, which
could possibly result in improved administration
techniques. These methods could be based upon the
measurement of various physiological parameters,
such as tumour temperature; the latter revealing the
intensity of the tumour cellular metabolism, as well
as the importance of the tumour vascular output
(Gautherie et al., 1975a,b). Both these factors seem
to be closely linked.
Some investigators have already shown the
relationship between the malignancy of mammary
tumours and their heat production (Gautherie et
al., 1975a, b; Moller & Bojsen, 1980). Moreover,
radiotherapy induces a hypothermic phase in the
responding tumours (Gautherie et al., 1975c). Thus,
the decreased malignant potential of the tumours,
which is induced by the administration of cytostatic
drugs might be expressed by tumour hypothermia
as has been recently demonstrated in rats by
inducing regression of the ISIS 130 and ISIS 208
immunocytomas with cyclophosphamide (Nickers et
al., 1986).
In this study, the external temperature of the
verychemosensitive ISIS 130 tumour was investigated
after treatment with increasing doses of different
cytostatic drugs. The possible relationship between
the thermic behaviour of this tumour and the
reduction in surface area induced by the drugs was
examined.
Materials and methods
Animals and tumour transplantation
LOU rats from our own substrain (LOU/dec) were
used. These were kept in cages of 4 animals and in
an artificial cycle of dark periods (7p.m.-7a.m.)
and light periods (7a.m.-7p.m.). They were given a
commercial pelleted diet (type A03-U.A.R.,
Villemoison-sur-Orge, France) as well as water ad
libitum. The temperature of the room in which they
stayed from the day of tumour engraftment till the
end of the experiment, was kept constant between
210 and 22°C.
Immunocytoma ISIS 130 was used (Deckers et
al., 1973, 1977). This tumour arose spontaneously
in the LOU/dec substrain in 1964. Microscopically,
the neoplasm consists of undifferentiated large cells
with large nuclei containing 1-3 nucleoli. It
originally secreted immunoglobulin G, but since
1975 he lost this monoclonal component secretion.
At the time when the present study was carried out,
the tumour showed the same characteristics
(histology, surface doubling time, survival time of
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the untreated rats after injection of malignant cells
as described initially (Deckers et al., 1973, 1977).
The tumour was transplanted by grafting 106 viable
cells s.c. in the right flank of young adult male rats.
Tumour growth
The size of the tumours was expressed in surface
values (mm2) obtained by multiplying the two
longest perpendicular dimensions, which were
measured with calipers. These dimensions have
been measured every day from the beginning till the
end of the experiment.
Thermic measurements
The external temperature of tumour (TT) was
measured 30sec after the placement of a thermic
probe (YSI model 408; Yellow Springs Instrument
Co., Ohio, USA) upon the surface of the tumour,
always in the same place.
The rectal temperature (RT) was measured 20sec
after introducing a YSI probe (model 402) 2cm
into the rectum. The reading device (Tele-
Thermometer YSI model 43) was connected to a
BD401 registrator (Kipp & Zonen, The
Netherlands) to obtain a print-out of the results.
This method allowed us to measure the
temperatures to an accuracy of 0.1°C. We have
recorded the thermal behaviour of the tumour using
the DELTA T (DT) obtained after subtracting RT
and TT (DT=TT-RT).
Tumour treatment
As soon as the tumours reached an average surface
of 950mMn2, the hair was removed under
anaesthesia (with a 2% 2,2,2-tribromoethanol
solution) with an epilating cream, without inducing
cutaneous trauma. The rats were then distributed,
according to the size of the tumour surface, into
groups of 12 individuals. The mean values were
equal in every group, being 950mm2 (with a
standard deviation of 200mm2 in each group). The
day of epilation was considered to be day 1 of the
experiment, and from this time on, measurements
of the tumour surfaces were made every day at
11 a.m., while the thermal measurements were
initiated on day 2 at 6p.m. After this, they were
taken at 7a.m. and 6-p.m. every day till the end of
the experiment. The cytostatic drugs were
administered on day 4, at 12a.m., in a single i.v.
injection (tail vein). Untreated rats were injected
with physiological saline only. Table I shows the
various doses (mgm-2) of the different cytostatic
drugs administered. Each dose was tested in a
group of 12 rats. The administered doses of each
drug ranged from dose zero (untreated rats) to a
low dose having no effect upon the tumour, up to a
Table I Doses administered and LD50 for the five
cytostatic drugs used
(mgm 2)
Drug Doses administereda LD ob
Vinblastine 0.3, 0.7, 2, 5, 7, 9, 12 24
cis-Platinum 0.5, 1, 2, 3.5, 6, 11, 21 48
Methotrexate 1, 3, 5, 11, 16, 21, 32 >400
Doxorubicin 0.5, 1, 2, 3.5, 6, 11, 21 43
Cyclophosphamide 2.5, 5, 15, 25, 50, 100 720
aSingle i.v. injection; bDetermined on normal LOU/dec
rats.
dose inducing a more than 50% regression of the
tumour surface, without exceeding, however, half of
the LD50 of the cytostatic drug. The end of the
experiment was always fixed at day 11, when most
of the tumours started growing again. A total of
468 rats has been investigated in 5 successive
experiments (1 experiment for each cytostatic drug).
Measurement ofdrug-induced tumour regression and
TT decrease
The size of tumour surface prior to the
administration of the cytostatic drugs, represents
the reference value, from which the reference line
RLI) was drawn (Figure IA). The temporal
integration (F(S)) of the surface between RL1 and
the curve of the measured surfaces at a later time
was used to quantify the effective response to the
cytostatic drugs. The greater the decrease in tumour
size, the larger was the increase in F(S). As tegards
the temperature measurements, the mean value of
the first four DT preceding the administration of
the cytostatic agents (two of them having been
taken at 7a.m. and two at 6p.m.) represents the
reference value, from which the reference line (RL2)
has been drawn (Figure iB). The temporal
integration (F(T)) of the surface between RL2 and
the curve of the DT obtained later on was used to
quantify the thermal response of the tumour to
chemotherapy.
Results
For every cytostatic drug tested, negative or zero
DT were observed throughout these experiments (in
the range from -4° to 0WC), indicating that TT was
equal to or lower than RT (Figure IB). Any drop in
the DT lines (Figure 1B) resulted from a decrease in
TT and not from an increase in RT. No tendency
for RT to increase significantly was observed in any
group of rats in these assays. The greater theTUMOUR TEMPERATURE AND CHEMOTHERAPY 63
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Figure 1 A: Vinblastine-induced tumour regression plotted against time. F(S) of the 9mgm-2 dose is the
integration of the surface between the reference line RLl and the tumour surface curve (mean of 12 rats)
observed after drug administration. B: Vinblastine-induced DT decrease plotted against time. F(T) of the
9mgm-2 dose is the integration of the surface between the reference line RL2 and the DT curve observed
after drug administration. The higher the vinblastine dose, the greater the decrease in D(T) parameters and
the longer the delay in tumour regrowth. The decrease in DT followed by increase to previous level predicts
respectively tumour surface decrease and regrowth within 1-2 days.
decrease in TT and DT values was, after the
administration of the cytostatic drugs, the larger
was the increase of the F(T) values (Figure 1).
Figure 2 shows the relationship between the dose
and the tumouricidal effect, as expressed by the
parameters F(T) or F(S) for the different cytostatic
drugs. The maximal tumouricidal effect of cis-
platinum and cyclophosphamide was obtained with
the respective doses of 3.5 and 25mgm-2. At
lower doses and with other cytostatic drugs, a
linear relationship existed between the dose and the
parameters F(T) and F(S).
The calculation of the correlation coefficient (r)
showed that the link between F(T) and F(S) was
highly significant for vinblastine as well as for the
other cytostatic drugs; r was positive in all five
cases (Table II). Further statistical analysis (linear-
ity test) allowed us to consider the link between
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F(T) and F(S) to be linear in all of the five cases
considered.
Figure 3 represents the linear relationship be-
tween F(T) and F(S) for each of the 5 drugs. No
significant difference was found between the slopes
of these straight lines, which are in fact super-
imposable; the relationship between the thermal
decrease and the reduction of the tumour surface
may therefore be represented by the same straight
line, for whichever cytostatic drug was tested.
Table III and Figure lb show for every adminis-
tered cytostatic drug, the link between the
magnitude of the F(T) parameters and the delay
in tumour regrowth. The higher the value F(T), the
longer the delay in tumour regrowth. Increasing
doses of methotrexate, vinblastine and doxorubicin
are correlated with increasing F(T) values and delay
in tumour regrowth whereas with increasing doses
of cis-platinum and cyclophosphamide a maximum
F(T) value and the longest delay in tumour
regrowth are attained with respective doses of
3.5mgm-2 and 50mgm-2 (Table III).
As tumours regrow, the superficial temperatures
and D(T) parameters rise to previous levels or
become higher than before chemotherapy with
negative F(T) values (Figure lb).
The decrease in DT, followed by its increase to
previous levels predict respectively the decrease in
size and the regrowth of tumours treated with
vinblastine (Figure 1) and cis-platinum.
Discussion
Figure 2 Relationship between the dose and the
tumouricidal effect of the 5 cytostatic drugs, as
expressed by the parameters F(T) and F(S). The
maximal tumouricidal effect of cis-platinum and cyclo-
phosphamide is obtained with doses of 3.5 and
25mgm 2 respectively. At lower doses and with other
cytostatic drugs, a linear relationship exists between
the dose increase and the parameters F(T) and F(S).
The experimental tumour ISIS 130 has been inves-
tigated in the present study, because of its high
sensitivity to cytostatic drugs of different classes.
Thus, we have demonstrated that the analysis of
the transient external hypothermia occurring in this
subcutaneous tumour after chemotherapy (and
shown by a decrease in the DT values and increase
in F(T) values) allowed us to measure the efficiency
of various cytostatic drugs.
For whatever drug used, the same linear relation-
ship between the F(S) and F(T) parameters was
noted. External hypothermia of this tumour after
effective chemotherapy is therefore not linked to
any particular type of cytostatic agent; its extent
depends on the importance of the tumouricidal
effect which has been achieved.
The decrease in DT, followed by the increase to
previous levels predicts respectively the decrease in
size and the regrowth of tumours treated with
vinblastine and cis-platinum.
The temperature of the subcutaneous tumours
could be measured equally with intra-tumoural
probes or probes placed upon the tissue coveringTable II Correlation between F(T) and F(S) parameters for different cytostatic drugs
Correlation Statistical
Sample size coefficient significance
Drug (number ofrats) (r) (P)
Vinblastine 86 +0.64 <0.001
cis-Platinum 87 +0.60 <0.001
Methotrexate 90 +0.50 <0.001
Doxorubicin 87 +0.27 <0.02
Cyclophosphamide 82 +0.57 <0.001
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Figure 3 The linear relationship between F(T) and F(S) for five cytostatic drugs. There is no significant
difference between the slopes of these straight lines, which are superimposable.
Table III Link between the magnitude of the F(T) parameter and the delay in tumour regrowth after chemotherapy
Cyclophosphamide Doxorubicin Cis-Platinum Vinblastine Methotrexate
Dosea Daysb F(T)C Dose Days F(T) Dose Days F(T) Dose Days F(T) Dose Days F(T)
0 t 0.2 0 t 0.2 0 t 0.5 0 t 1.7 0 t 2.7
2.5 t 1.8 0.5 t 4.6 0.5 t 0.2 0.3 t 0.2 1 t 0.5
5 t 2.5 1 t 5.0 1 t 3.4 0.7 t 0.6 3 2 3.2
15 7 3.1 2 t 5.2 2 6 4.8 2 t 0.3 5 3 5.0
25 7 9.7 3.5 4 6.7 3.5 7 9.0 5 6 5.1 11 4 2.6
50 * 9.1 6 6 4.7 6 7 7.8 7 7 4.6 16 4 5.0
100 * 8.8 11 6 7.7 11 7 9.0 9 8 5.5 21 5 9.6
21 * 9.7 21 7 9.4 12 9 9.7 32 5 9.6
amgM-1; bDelay in tumour regrowth after chemotherapy; cArbitrary units; tNo tumour size decrease observed;
*No tumour regrowth observed.
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the tumours (Gautherie et al., 1975a,b). The
external temperatures are, of course, lower than the
intra-tumour ones, but both these parameters show
parallel variations by night and day (Gautherie et
al., 1975a,b; Moller & Bojsen, 1980). The same
parallel variation occurs, when tumour hypothermia
indicates a tumour response to radiotherapy
(Gautherie et al., 1975c).
Temperature measurement with external probes
is limited to superficial neoplasms, but has the
advantage of being simple and avoiding the risks
of inflammation and necrosis of the tumour tissue
around the catheter (Moller et al., 1980). Both
factors are extremely important for small volume
tumours, such as those which are handled in animal
experiments. Moreover, in contrast to intra-tumour
measurements, the ease of external temperature
measurements allows us to determine the relation-
ship between the doses of cytostatic drugs and the
parameters F(T) and F(S) with large numbers of
rats. Finally, the thermal significance of the peri-
tumoural vascularization of small volume experi-
mental tumours seems to be negligible (Moller et
al., 1980).
The temperature of a tumour depends on the
temperature of the grafted organism, on the
tumoural cellular metabolism and the vasculature.
The latter factors appear to be closely linked, but
measurement of the intra- or extra-tumoural tem-
peratures does not allow us to determine accurately
the respective fractions of the vascular and meta-
bolic components of the tumour temperature.
The application of the DT parameters allows us
to eliminate the influence of the general tempera-
ture of the grafted organism. These DT parameters
certainly appeared to be the most stable thermal
parameters in untreated control rats throughout
the experiments performed (Nickers et al., 1986).
How can the phenomenon of transient tumour
hypothermia be explained? Several authors have
demonstrated a relationship between the inalig-
nancy grade of mammary tumours and their
internal and external temperature (Gautherie et al.,
1975a). Moreover, radiotherapy induces a hypo-
thermic phase in the responding tumours (Gautherie
et al., 1975c).
Transient external hypothermia in the ISIS
130tumour characterizes the response to the differ-
ent cytostatic drugs. This external hypothermia thus
reveals the tumouricidal effect of the cytostatic
drugs as well as the transient paralysis of tumour
physiology.
The confirmation of these data in other experi-
mental tumours as well as in human tumour xeno-
grafts could lead clinically to a rapid and non-
invasive method of estimating the importance and
duration of action of the cytostatic drugs against
external tumours, such as those of head and neck
and breast as well as sarcomas, adenopathies and
probably bone metastases.
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